BRAF and cancer: We reasoned that TGFβ-receptor inactivation in human cancer—occurring as a result of defective mismatch repair (due to a microsatellite sequence in TGFBR2, missing from the mouse genome)29—might synergise with mutant BRAF to initiate right-sided colonic tumours.